Claims Analysis
Total Claims: 29
Claim 1
Independent Claim
435 words
A 9-Fluoroprostane derivative of the formula ##STR18## wherein R 1 is CH 2 OH or ##STR19## wherein R 2 is (a) hydrogen, (b) C 1-10 alkyl, (c) C 1-10 alkyl substituted by halogen; C 1-4 alkoxy; C 6-10 -aryl or aroyl; C 6-10 -aryl or aroyl each substituted by 1-3 halogen atoms, a phenyl group, 1-3 C 1-4 alkyl groups or a chloromethyl, fluoromethyl, trifluoromethyl, carboxy, hydroxy or C 1-4 alkoxy group; di-C 1-4 -alkylamino; or tri-C 1-4 -alkylammonium; (d) C 3-10 cycloalkyl, (e) C 3-10 cycloalkyl substituted by C 1-4 alkyl, (f) C 6-10 aryl, (g) C 6-10 aryl substituted by 1-3 halogen atoms, a phenyl group, 1-3 C 1-4 alkyl groups or a chloromethyl, fluoromethyl, trifluoromethyl, carboxy, hydroxy or C 1-4 alkoxy group, or (h) an aromatic heterocycle of 5 or 6 ring atoms, one or two of which are O, N or S, the remainder being carbon atoms; or R 1 is ##STR20## wherein R 3 is an acyl group of a hydrocarbon C 1-5 carboxylic or sulfonic acid or is one of the R 2 groups; A is --CH 2 --CH 2 -- or cis--CH═CH--; B is --CH 2 --CH 2 --, trans--CH═CH-- or C.tbd.C--; W is hydroxymethylene or RO-methylene, wherein the OR or OH group is in a α- or β-position; R is tetrahydropyranyl, tetrahydrofuranyl, α-ethoxyethyl, trimethylsilyl, dimethyl-tert-butylsilyl, tribenzylsilyl or an acyl group of a C 1-5 -hydrocarbon carboxylic or sulfonic acid. D and E jointly are a direct bond or D is straight-chain or branched alkylene or alkenylene of 1-10 carbon atoms, optionally substituted by 1-2 fluorine atoms and E is oxygen, sulfur, a direct bond, C.tbd.C-- or --CR 6 ═CR 7 -- wherein R 6 and R 7 differ from each other and each is hydrogen, chlorine or C 1-6 -alkyl; R 4 is OH or OR; R 5 is (a) a C 6-10 hydrocarbon aliphatic radical substituted by C 6-10 -aryl or by C 6-10 -aryl substituted by 1-3 halogen atoms, a phenyl group, 1-3 C 1-4 alkyl groups or a chloromethyl, fluoromethyl, trifluoromethyl, caboxy, hydroxy or C 1-4 alkoxy group; (b) C 3-10 cycloalkyl, (c) C 3-10 cycloalkyl substituted by C 1-4 alkyl; (d) C 6-10 aryl, (e) C 6-10 aryl substituted by 1-3 halogen atoms, a phenyl group, 1-3 C 1-4 alkyl groups or a chloromethyl, fluoromethyl, trifluoromethyl, carboxy, hydroxy or C 1-4 alkoxy group; or (f) an aromatic heterocycle of 5 or 6 ring atoms, one or two of which are O, N or S, the remainder being carbon atoms; or when R 2 is hydrogen, a physiologically compatible salt thereof with a base.
Claim 2
Dependent Claim
435 words
A 9-Fluoroprostane derivative of the formula ##STR18## wherein R 1 is CH 2 OH or ##STR19## wherein R 2 is (a) hydrogen, (b) C 1-10 alkyl, (c) C 1-10 alkyl substituted by halogen; C 1-4 alkoxy; C 6-10 -aryl or aroyl; C 6-10 -aryl or aroyl each substituted by 1-3 halogen atoms, a phenyl group, 1-3 C 1-4 alkyl groups or a chloromethyl, fluoromethyl, trifluoromethyl, carboxy, hydroxy or C 1-4 alkoxy group; di-C 1-4 -alkylamino; or tri-C 1-4 -alkylammonium; (d) C 3-10 cycloalkyl, (e) C 3-10 cycloalkyl substituted by C 1-4 alkyl, (f) C 6-10 aryl, (g) C 6-10 aryl substituted by 1-3 halogen atoms, a phenyl group, 1-3 C 1-4 alkyl groups or a chloromethyl, fluoromethyl, trifluoromethyl, carboxy, hydroxy or C 1-4 alkoxy group, or (h) an aromatic heterocycle of 5 or 6 ring atoms, one or two of which are O, N or S, the remainder being carbon atoms; or R 1 is ##STR20## wherein R 3 is an acyl group of a hydrocarbon C 1-5 carboxylic or sulfonic acid or is one of the R 2 groups; A is --CH 2 --CH 2 -- or cis--CH═CH--; B is --CH 2 --CH 2 --, trans--CH═CH-- or C.tbd.C--; W is hydroxymethylene or RO-methylene, wherein the OR or OH group is in a α- or β-position; R is tetrahydropyranyl, tetrahydrofuranyl, α-ethoxyethyl, trimethylsilyl, dimethyl-tert-butylsilyl, tribenzylsilyl or an acyl group of a C 1-5 -hydrocarbon carboxylic or sulfonic acid. D and E jointly are a direct bond or D is straight-chain or branched alkylene or alkenylene of 1-10 carbon atoms, optionally substituted by 1-2 fluorine atoms and E is oxygen, sulfur, a direct bond, C.tbd.C-- or --CR 6 ═CR 7 -- wherein R 6 and R 7 differ from each other and each is hydrogen, chlorine or C 1-6 -alkyl; R 4 is OH or OR; R 5 is (a) a C 6-10 hydrocarbon aliphatic radical substituted by C 6-10 -aryl or by C 6-10 -aryl substituted by 1-3 halogen atoms, a phenyl group, 1-3 C 1-4 alkyl groups or a chloromethyl, fluoromethyl, trifluoromethyl, caboxy, hydroxy or C 1-4 alkoxy group; (b) C 3-10 cycloalkyl, (c) C 3-10 cycloalkyl substituted by C 1-4 alkyl; (d) C 6-10 aryl, (e) C 6-10 aryl substituted by 1-3 halogen atoms, a phenyl group, 1-3 C 1-4 alkyl groups or a chloromethyl, fluoromethyl, trifluoromethyl, carboxy, hydroxy or C 1-4 alkoxy group; or (f) an aromatic heterocycle of 5 or 6 ring atoms, one or two of which are O, N or S, the remainder being carbon atoms; or when R 2 is hydrogen, a physiologically compatible salt thereof with a base.
Claim 3
Dependent Claim
17 words
A compound of claim 1 wherein B-W-D-E-R 5 is ##STR21## wherein Y 1 is halo or H.
Claim 4
Dependent Claim
8 words
(5Z,13E)-(9R,11R,15R)-11,15-Dihydroxy-9-fluoro-16-phenoxy-17,18,19,20-tetranor-5,13-prostadienoic acid methyl ester, compound of claim 1.
Claim 5
Dependent Claim
9 words
(5Z,13E)-(9S,11R,15R)-11,15-Dihydroxy-9-fluoro-16-phenoxy-17,18,19,20-tetranor-5,13-prostadienoic acid methyl ester, a compound of claim 1.
Claim 6
Dependent Claim
9 words
(13E)-(9R,11R,15R)-11,15-Dihydroxy-9-fluoro-16-phenoxy-17,18,19,20-tetranor-13-prostenoic acid methyl ester, a compound of claim 1.
Claim 7
Dependent Claim
9 words
(13E)-(9S,11R,15R)-11,15-Dihydroxy-9-fluoro-16-phenoxy-17,18,19,20-tetranor-13-prostenoic acid methyl ester, a compound of claim 1.
Claim 8
Dependent Claim
7 words
(5Z,13E)-(9R,11R,15R)-11,15-Dihydroxy-9-fluoro-16-phenoxy-17,18,19,20-tetranor-5,13-prostadienoic acid, a compound of claim 1.
Claim 9
Dependent Claim
7 words
(5Z,13E)-(9S,11R,15R)-11,15-Dihydroxy-9-fluoro-16-phenoxy-17,18,19,20-tetranor-5,13-prostadienoic acid, a compound of claim 1.
Claim 10
Dependent Claim
7 words
(13E)-(9R,11R,15R)-11,15-Dihydroxy-9-fluoro-16-phenoxy-17,18,19,20-tetranor-13-prostenoic acid, a compound of claim 1.
Claim 11
Dependent Claim
7 words
(13E)-(9S,11R,15R)-11,15-Dihydroxy-9-fluoro-16-phenoxy-17,18,19,20-tetranor-13-prostenoic acid, a compound of claim 1.
Claim 12
Dependent Claim
6 words
(13E)-(9R,11R,15R)-9-Fluoro-1,11,15-trihydroxy-16-phenoxy-17,18,19,20-tetranor-13-prostene, a compound of claim 1.
Claim 13
Dependent Claim
6 words
(13E)-(9S,11R,15R)-9-Fluoro-1,11,15-trihydroxy-16-phenoxy-17,18,19,20-tetranor-13-prostene, a compound of claim 1.
Claim 14
Dependent Claim
8 words
(13E)-(9R,11R,15R)-11,15-Dihydroxy-9-fluoro-16-phenoxy-17,18,19,20-tetranor-13-prostenoic acid methylsulfonamide, a compound of claim 1.
Claim 15
Dependent Claim
8 words
(13E)-(9S,11R,15R)-11,15-Dihydroxy-9-fluoro-16-phenoxy-17,18,19,20-tetranor-13-prostenoic acid methylsulfonamide, a compound of claim 1.
Claim 16
Dependent Claim
8 words
(13E)-(9R,11R,15R)-11,15-Dihydroxy-9-fluoro-16-phenoxy-17,18,19,20-tetranor-13-prostenoic acid isopropylsulfonamide, a compound of claim 1.
Claim 17
Dependent Claim
8 words
(13E)-(9R,11R,15R)-11,15-Dihydroxy-9-fluoro-16-phenoxy-17,18,19,20-tetranor-13-prostenoic acid acetylamide, a compound of claim 1.
Claim 18
Dependent Claim
8 words
(13E)-(9R,11R,15R)-11,15-Dihydroxy-9-fluoro-16-phenoxy-17,18,19,20-tetranor-13-prostenoic acid amide, a compound of claim 1.
Claim 19
Dependent Claim
9 words
(5Z,13E)-(9R,11R,15R)-11,15-Dihydroxy-9-fluoro-16-phenoxy-17,18,19,20-tetranor-5,13-prostadienoic acid tris(hydroxymethyl)aminomethane salt, a compound of claim 1.
Claim 20
Dependent Claim
21 words
A pharmaceutical composition comprising an amount of a compound of claim 1 effective to trigger luteolysis and a pharmaceutically acceptable carrier.
Claim 21
Dependent Claim
37 words
A method of achieving a luteolytic effect in a patient in whom it is desired to achieve such an effect comprising administering to the patient an amount of a compound of claim 1 effective to trigger luteolysis.
Claim 22
Dependent Claim
410 words
A 9-Fluoroprostane derivative of the formula ##STR22## wherein R 1 is CH 2 OH or ##STR23## wherein R 2 is (a) hydrogen, (b) C 1-10 alkyl, (c) C 1-10 alkyl substituted by halogen; C 1-14 alkoxy; C 6-10 -aryl or aroyl; C 6-10 -aryl or aroyl each substituted by 1-3 halogen atoms, a phenyl group, 1-3 C 1-4 alkyl groups or a chloromethyl, fluoromethyl, trifluoromethyl, carboxy, hydroxy or C 1-4 alkoxy group; di-C 1-4 -alkylamino; or tri-C 1-4 -alkylammonium; (d) C 3-10 cycloalkyl, (e) C 3-10 cycloalkyl substituted by C 1-4 alkyl, (f) C 6-10 aryl, (g) C 6-10 aryl substituted by 1-3 halogen atoms, a phenyl group, 1-3 C 1-4 alkyl groups or a chloromethyl, fluoromethyl, trifluoromethyl, carboxy, hydroxy or C 1-4 alkoxy group, or (h) an aromatic heterocycle of 5 or 6 ring atoms, one or two of which are O, N or S, the remainder being carbon atoms; or R 1 is ##STR24## wherein R 3 is an acyl group of a hydrocarbon C 1-15 carboxylic or sulfonic acid or is one of the R 2 groups; A is --CH 2 --CH 2 -- or cis--CH═CH--; B is --CH 2 --CH 2 --, trans--CH═CH-- or C.tbd.C--; W is hydroxymethylene or RO-methylene, wherein the OR or OH group is in a α- or β-position; R is tetrahydropyranyl, tetrahydrofuranyl, α-ethoxyethyl, trimethylsilyl, dimethyl-tert-butylsilyl, tribenzylsilyl or an acyl group of a C 1-15 -hydrocarbon carboxylic or sulfonic acid, D is straight-chain or branched alkylene or alkenylene of 1-10 carbon atoms, optionally substituted substituted by 1-2 fluorine atoms and E is oxygen, sulfur or C.tbd.C--; R 4 is OH or OR; R 5 is (a) hydrogen, (b) a C 1-10 hydrocarbon aliphatic radical, (c) a C 6-10 hydrocarbon aliphatic radical substituted by halogen, C 6-10 -aryl or by C 6-10 -aryl substituted by 1-3 halogen atoms, a phenyl group, 1-3 C 1-4 alkyl groups or a chloromethyl, fluoromethyl, trifluoromethyl, carboxy, hydroxy or C 1-4 alkoxy group; (d) C 3-10 cycloalkyl, (e) C 3-10 cycloalkyl substituted by C 1-4 alkyl; (f) C 6-10 aryl, (g) C 6-10 aryl substituted by 1-3 halogen atoms, a phenyl group, 1-3 C 1-4 alkyl groups or a chloromethyl, fluoromethyl, trifluoromethyl, carboxy, hydroxy or C 1-4 alkoxy group; or (h) an aromatic heterocyce of 5 or 6 ring atoms, one or two of which are O, N or S, the remainder being carbon atoms; or when R 2 is hydrogen a physiologically compatible salt thereof with a base.
Claim 23
Dependent Claim
410 words
A 9-Fluoroprostane derivative of the formula ##STR22## wherein R 1 is CH 2 OH or ##STR23## wherein R 2 is (a) hydrogen, (b) C 1-10 alkyl, (c) C 1-10 alkyl substituted by halogen; C 1-14 alkoxy; C 6-10 -aryl or aroyl; C 6-10 -aryl or aroyl each substituted by 1-3 halogen atoms, a phenyl group, 1-3 C 1-4 alkyl groups or a chloromethyl, fluoromethyl, trifluoromethyl, carboxy, hydroxy or C 1-4 alkoxy group; di-C 1-4 -alkylamino; or tri-C 1-4 -alkylammonium; (d) C 3-10 cycloalkyl, (e) C 3-10 cycloalkyl substituted by C 1-4 alkyl, (f) C 6-10 aryl, (g) C 6-10 aryl substituted by 1-3 halogen atoms, a phenyl group, 1-3 C 1-4 alkyl groups or a chloromethyl, fluoromethyl, trifluoromethyl, carboxy, hydroxy or C 1-4 alkoxy group, or (h) an aromatic heterocycle of 5 or 6 ring atoms, one or two of which are O, N or S, the remainder being carbon atoms; or R 1 is ##STR24## wherein R 3 is an acyl group of a hydrocarbon C 1-15 carboxylic or sulfonic acid or is one of the R 2 groups; A is --CH 2 --CH 2 -- or cis--CH═CH--; B is --CH 2 --CH 2 --, trans--CH═CH-- or C.tbd.C--; W is hydroxymethylene or RO-methylene, wherein the OR or OH group is in a α- or β-position; R is tetrahydropyranyl, tetrahydrofuranyl, α-ethoxyethyl, trimethylsilyl, dimethyl-tert-butylsilyl, tribenzylsilyl or an acyl group of a C 1-15 -hydrocarbon carboxylic or sulfonic acid, D is straight-chain or branched alkylene or alkenylene of 1-10 carbon atoms, optionally substituted substituted by 1-2 fluorine atoms and E is oxygen, sulfur or C.tbd.C--; R 4 is OH or OR; R 5 is (a) hydrogen, (b) a C 1-10 hydrocarbon aliphatic radical, (c) a C 6-10 hydrocarbon aliphatic radical substituted by halogen, C 6-10 -aryl or by C 6-10 -aryl substituted by 1-3 halogen atoms, a phenyl group, 1-3 C 1-4 alkyl groups or a chloromethyl, fluoromethyl, trifluoromethyl, carboxy, hydroxy or C 1-4 alkoxy group; (d) C 3-10 cycloalkyl, (e) C 3-10 cycloalkyl substituted by C 1-4 alkyl; (f) C 6-10 aryl, (g) C 6-10 aryl substituted by 1-3 halogen atoms, a phenyl group, 1-3 C 1-4 alkyl groups or a chloromethyl, fluoromethyl, trifluoromethyl, carboxy, hydroxy or C 1-4 alkoxy group; or (h) an aromatic heterocyce of 5 or 6 ring atoms, one or two of which are O, N or S, the remainder being carbon atoms; or when R 2 is hydrogen a physiologically compatible salt thereof with a base.
Claim 24
Dependent Claim
21 words
A pharmaceutical composition comprising an amount of a compound of claim 21 effective to trigger luteolysis and a pharmaceutically acceptable carrier.
Claim 25
Dependent Claim
37 words
A method of achieving a luteolytic effect in a patient in whom it is desired to achieve such an effect comprising administering to the patient an amount of a compound of claim 21 effective to trigger luteolysis.
Claim 26
Dependent Claim
24 words
A pharmaceutical composition comprising an amount of a compound of claim 1 effective to reduce swelling of nasal mucous membranes and a pharmaceutically-acceptable carrier.
Claim 27
Dependent Claim
13 words
A pharmaceutical composition of claim 24, wherein the active ingredient is (5Z,13E)-(9R,11R,15R)-11,15-dihydroxy-9-fluoro-16-phenoxy-17,18,19,20-tetranor-5,13-prostadienoic acid.
Claim 28
Dependent Claim
39 words
A method of reducing the swelling of nasal mucous membranes a patient in need of such treatment comprising administering to the patient an amount of a compound of claim 1 effective to reduce the swelling of nasal mucous membranes.
Claim 29
Dependent Claim
12 words
A method of claim 26 wherein the active ingredient is (5Z,13E)-(9R,11R,15R)-11,15-dihydroxy-9-fluoro-16-phenoxy-17,18,19,20-tetranor-5,13-prostadienoic acid.